相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mechanisms of SARS-CoV-2 entry into cells
Cody B. Jackson et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2022)
What reinfections mean for COVID-19
Akiko Iwasaki
LANCET INFECTIOUS DISEASES (2021)
A case of COVID-19 reinfection in the UK
Jack West et al.
CLINICAL MEDICINE (2021)
Oxford-AstraZeneca COVID-19 vaccine efficacy
Maria Deloria Knoll et al.
LANCET (2021)
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
Merryn Voysey et al.
LANCET (2021)
The Perspective of Coronavirus Disease Outbreak: Epidemiology, Transmission, and Possible Treatment
Ab Qayoom Naik et al.
VECTOR-BORNE AND ZOONOTIC DISEASES (2021)
Stabilizing the closed SARS-CoV-2 spike trimer
Jarek Juraszek et al.
NATURE COMMUNICATIONS (2021)
The BNT162b2 (BioNTech/Pfizer) vaccine had 95% efficacy against COVID-19 >= 7 days after the 2nd dose
Zain Chagla
ANNALS OF INTERNAL MEDICINE (2021)
Different mutations in SARS-CoV-2 associate with severe and mild outcome
Adam Nagy et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2021)
The Johnson & Johnson Vaccine for COVID-19
Edward H. Livingston et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Sputnik V COVID-19 vaccine candidate appears safe and effective Comment
Ian Jones et al.
LANCET (2021)
'KILLER' T CELLS COULD BOOST COVID IMMUNITY AMID NEW VARIANTS
Heidi Ledford
NATURE (2021)
COVID VACCINES AND SAFETY: WHAT THE RESEARCH SAYS
Ariana Remmel
NATURE (2021)
Causes of death and comorbidities in hospitalized patients with COVID-19
Sefer Elezkurtaj et al.
SCIENTIFIC REPORTS (2021)
Covid-19: Russian vaccine efficacy is 91.6%, show phase III trial results
Elisabeth Mahase
BMJ-BRITISH MEDICAL JOURNAL (2021)
SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates
Nikolaos C. Kyriakidis et al.
NPJ VACCINES (2021)
COVID-19 vaccine decisions: considering the choices and opportunities
Peter J. Hotez et al.
MICROBES AND INFECTION (2021)
COVID-19 Vaccines: Current Conditions and Future Prospects
Tarek Zieneldien et al.
BIOLOGY-BASEL (2021)
Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant
V. Shinde et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose
Catherine J. Reynolds et al.
SCIENCE (2021)
Prevention of hepatitis B mother-to-child transmission in Namibia: A cost-effectiveness analysis
Cynthia Raissa Tamandjou Tchuem et al.
VACCINE (2021)
Efficacy of Birth Dose Vaccination in Preventing Mother-to-Child Transmission of Hepatitis B: A Randomized Controlled Trial Comparing Engerix-B and Sci-B-Vac
Rifaat Safadi et al.
VACCINES (2021)
Neutralizing Antibody Responses in COVID-19 Convalescent Sera
William T. Lee et al.
JOURNAL OF INFECTIOUS DISEASES (2021)
Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries
Marc Brisson et al.
LANCET (2020)
Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies
Syed Faraz Ahmed et al.
VIRUSES-BASEL (2020)
Cell entry mechanisms of SARS-CoV-2
Jian Shang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Effectiveness of convalescent plasma therapy in severe COVID-19 patients
Kai Duan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Controversial treatments: An updated understanding of the coronavirus disease 2019
Cantong Zhang et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Angiotensin-converting enzyme 2 (ACE2),SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19)
Arno R. Bourgonje et al.
JOURNAL OF PATHOLOGY (2020)
New Insights of Emerging SARS-CoV-2: Epidemiology, Etiology, Clinical Features, Clinical Treatment, and Prevention
Gangqiang Guo et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19
Yuan Huang et al.
ACTA PHARMACOLOGICA SINICA (2020)
A Review of Remdesivir for COVID-19: Data to Date
Monica Mehta et al.
CARDIOLOGY IN REVIEW (2020)
Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past
Vibhuti Kumar Shah et al.
FRONTIERS IN IMMUNOLOGY (2020)
mRNA Vaccines: Possible Tools to Combat SARS-CoV-2
Changhua Yi et al.
VIROLOGICA SINICA (2020)
Monoclonal antibody as a potential anti-COVID-19
Leila Jahanshahlu et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Rapid and Impressive Response to a Combined Treatment with Single-Dose Tocilizumab and NIV in a Patient with COVID-19 Pneumonia/ARDS
Marco Cascella et al.
MEDICINA-LITHUANIA (2020)
CORONAVIRUS VACCINES PASS SAFETY TRIALS BUT NO LEADER EMERGES
Ewen Callaway
NATURE (2020)
Vaccine Candidates against Coronavirus Infections. Where Does COVID-19 Stand?
Jawad Al-Kassmy et al.
VIRUSES-BASEL (2020)
COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses
Ugur Sahin et al.
NATURE (2020)
Convalescent plasma treatment of severe COVID-19: a propensity score-matched control study
Sean T. H. Liu et al.
NATURE MEDICINE (2020)
Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine
Cheryl Keech et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Convalescent plasma transfusion therapy in severe COVID-19 patients- a safety, efficacy and dose response study: A structured summary of a study protocol of a phase II randomized controlled trial
Fazle Rabbi Chowdhury et al.
TRIALS (2020)
The Russian vaccine for COVID-19
Talha Khan Burki
LANCET RESPIRATORY MEDICINE (2020)
A Review of the Progress and Challenges of Developing a Vaccine for COVID-19
Omna Sharma et al.
FRONTIERS IN IMMUNOLOGY (2020)
Covid-19: Oxford vaccine is up to 90% effective, interim analysis indicates
Elisabeth Mahase
BMJ-BRITISH MEDICAL JOURNAL (2020)
Covid-19: What have we learnt about the new variant in the UK?
Elisabeth Mahase
BMJ-BRITISH MEDICAL JOURNAL (2020)
Analysis of Indian SARS-CoV-2 Genomes Reveals Prevalence of D614G Mutation in Spike Protein Predicting an Increase in Interaction With TMPRSS2 and Virus Infectivity
Sunil Raghav et al.
FRONTIERS IN MICROBIOLOGY (2020)
Designing spike protein (S-Protein) based multi-epitope peptide vaccine against SARS COVID-19 by immunoinformatics
Hitesh Singh et al.
HELIYON (2020)
COVID-19 reinfection - An enigmatic public health threat
Karthikeyan P. Iyengar et al.
MONALDI ARCHIVES FOR CHEST DISEASE (2020)
ACE2: The Major Cell Entry Receptor for SARS-CoV-2
Filippo Scialo et al.
LUNG (2020)
Compassionate use of convalescent plasma for treatment of moderate and severe pneumonia in COVID-19 patients and association with IgG antibody levels in donated plasma
Yasmin Maor et al.
ECLINICALMEDICINE (2020)
The SARS-CoV-2 Vaccine Pipeline: an Overview
Wen-Hsiang Chen et al.
CURRENT TROPICAL MEDICINE REPORTS (2020)
How COVID-19 induces cytokine storm with high mortality
Shintaro Hojyo et al.
INFLAMMATION AND REGENERATION (2020)
Updated insights into the mechanism of action and clinical profile of the immunoadjuvant QS-21: A review
Marie-Aleth Lacaille-Dubois
PHYTOMEDICINE (2019)
Evolution of cross-neutralizing antibodies and mapping epitope specificity in plasma of chronic HIV-1-infected antiretroviral therapy-naive children from India
Muzamil A. Makhdoomi et al.
JOURNAL OF GENERAL VIROLOGY (2017)
Human Immunodeficiency Virus Immune Cell Receptors, Coreceptors, and Cofactors: Implications for Prevention and Treatment
Andrew W. Woodham et al.
AIDS PATIENT CARE AND STDS (2016)
Structure, Function, and Evolution of Coronavirus Spike Proteins
Fang Li
ANNUAL REVIEW OF VIROLOGY, VOL 3 (2016)
Malaria DNA vaccine gp96NTD-CSP elicits both CSP-specific antibody and CD8+ T cell response
Zhangping Tan et al.
PARASITOLOGY RESEARCH (2015)
Peptide-Based Immunotherapeutics and Vaccines 2015
Pedro Reche et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2015)
Toward global prevention of sexually transmitted infections (STIs): The need for STI vaccines
Sami L. Gottlieb et al.
VACCINE (2014)
Aluminum Hydroxide Adjuvant Differentially Activates the Three Complement Pathways with Major Involvement of the Alternative Pathway
Esin Guven et al.
PLOS ONE (2013)
DNA Prime-Adenovirus Boost Immunization Induces a Vigorous and Multifunctional T-Cell Response against Hepadnaviral Proteins in the Mouse and Woodchuck Model
Anna D. Kosinska et al.
JOURNAL OF VIROLOGY (2012)
The safety evaluation of adjuvants during vaccine development: The AS04 experience
Nathalie Garcon et al.
VACCINE (2011)
Immunostimulatory CpG oligonucleotides: Effect on gene expression and utility as vaccine adjuvants
Dennis M. Klinman et al.
VACCINE (2010)
Immunity and immunopathology to viruses: what decides the outcome?
Barry T. Rouse et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Innate immune response to viral infection
Shohei Koyama et al.
CYTOKINE (2008)
DNA gag/adenovirus type 5 (Ad5) gag and Ad5 gag/Ad5 gag vaccines induce distinct T-cell response profiles
Kara S. Cox et al.
JOURNAL OF VIROLOGY (2008)
Correlates of antibody-mediated protection against HIV infection
Quentin Sattentau
CURRENT OPINION IN HIV AND AIDS (2008)
Distinct pathways of antigen uptake and intracellular routing in CD4 and CD8 T cell activation
Sven Burgdorf et al.
SCIENCE (2007)
Peptide-based therapeutic vaccines for allergic and autoimmune diseases
M Larché et al.
NATURE MEDICINE (2005)
Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis
I Hamming et al.
JOURNAL OF PATHOLOGY (2004)
Vaccine adjuvants: Current state and future trends
N Petrovsky et al.
IMMUNOLOGY AND CELL BIOLOGY (2004)
Subacute meningoencephalitis in a subset of patients with AD after Aβ42 immunization
JM Orgogozo et al.
NEUROLOGY (2003)
分享论文
